Neoadjuvant Study of Nab-paclitaxel Plus Carboplatin in Breast Cancer

NCT01625429 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: nab-paclitaxel

Sponsor

Shanghai Cancer Hospital, China